25 XP   0   0   10

Harbin Medisan Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Medisan together

PenkeI guess you are interested in Harbin Medisan Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Harbin Medisan Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Harbin Medisan Pharmaceutical Co Ltd

I send you an email if I find something interesting about Harbin Medisan Pharmaceutical Co Ltd.

Quick analysis of Medisan (30 sec.)










What can you expect buying and holding a share of Medisan? (30 sec.)

How much money do you get?

How much money do you get?
¥0.05
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥6.74
Expected worth in 1 year
¥7.05
How sure are you?
78.9%

+ What do you gain per year?

Total Gains per Share
¥0.64
Return On Investment
6.4%

For what price can you sell your share?

Current Price per Share
¥9.93
Expected price per share
¥6.74 - ¥10.79
How sure are you?
50%

1. Valuation of Medisan (5 min.)




Live pricePrice per Share (EOD)

¥9.93

Intrinsic Value Per Share

¥-12.24 - ¥-14.66

Total Value Per Share

¥-5.50 - ¥-7.92

2. Growth of Medisan (5 min.)




Is Medisan growing?

Current yearPrevious yearGrowGrow %
How rich?$295.2m$287.2m$1.8m0.7%

How much money is Medisan making?

Current yearPrevious yearGrowGrow %
Making money$2.3m-$5.7m$8.1m342.7%
Net Profit Margin5.5%-17.7%--

How much money comes from the company's main activities?

3. Financial Health of Medisan (5 min.)




What can you expect buying and holding a share of Medisan? (5 min.)

Welcome investor! Medisan's management wants to use your money to grow the business. In return you get a share of Medisan.

What can you expect buying and holding a share of Medisan?

First you should know what it really means to hold a share of Medisan. And how you can make/lose money.

Speculation

The Price per Share of Medisan is ¥9.93. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Medisan.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Medisan, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥6.74. Based on the TTM, the Book Value Change Per Share is ¥0.08 per quarter. Based on the YOY, the Book Value Change Per Share is ¥-0.21 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.08 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Medisan.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.000.0%0.010.1%-0.02-0.2%0.010.1%0.010.1%
Usd Book Value Change Per Share0.020.2%0.010.1%-0.03-0.3%0.050.5%0.050.5%
Usd Dividend Per Share0.000.0%0.010.1%0.010.1%0.010.1%0.010.1%
Usd Total Gains Per Share0.020.2%0.020.2%-0.02-0.2%0.060.6%0.060.6%
Usd Price Per Share1.84-1.83-2.23-2.04-2.04-
Price to Earnings Ratio132.45-93.38-325.06-84.68-84.68-
Price-to-Total Gains Ratio79.40-95.77-310.81-725.41-725.41-
Price to Book Ratio1.97-2.01-2.45-2.27-2.27-
Price-to-Total Gains Ratio79.40-95.77-310.81-725.41-725.41-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.374312
Number of shares727
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share0.010.05
Usd Total Gains Per Share0.020.06
Gains per Quarter (727 shares)15.9844.88
Gains per Year (727 shares)63.92179.53
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
133315437143170
2666211874285350
39993182110428530
4132124246147571710
5165155310184714890
61981863742218561070
72312164382589991250
826424750229411421430
929727856633112851610
1033030963036814271790

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%10.02.00.083.3%15.04.00.078.9%15.04.00.078.9%15.04.00.078.9%
Book Value Change Per Share3.01.00.075.0%5.07.00.041.7%9.010.00.047.4%9.010.00.047.4%9.010.00.047.4%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%19.00.00.0100.0%19.00.00.0100.0%19.00.00.0100.0%
Total Gains per Share4.00.00.0100.0%9.03.00.075.0%15.04.00.078.9%15.04.00.078.9%15.04.00.078.9%

Fundamentals of Medisan

About Harbin Medisan Pharmaceutical Co Ltd

Harbin Medisan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical product and medical devices in China. The company offers various drugs for nervous system, cardiovascular system, musculoskeletal system, systemic anti-infective, basic infusions, nutritional infusion, anti-tumor and immunomodulators, digestive tract, metabolism, etc. It also produces and sells cosmetics. Harbin Medisan Pharmaceutical Co., Ltd. was founded in 1996 and is headquartered in Harbin, China.

Fundamental data was last updated by Penke on 2024-03-11 01:40:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Harbin Medisan Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Medisan earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Medisan to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 2.8% means that ¥0.03 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Harbin Medisan Pharmaceutical Co Ltd:

  • The MRQ is 2.8%. The company is making a profit. +1
  • The TTM is 5.5%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ2.8%TTM5.5%-2.7%
TTM5.5%YOY-17.7%+23.2%
TTM5.5%5Y12.0%-6.5%
5Y12.0%10Y12.0%0.0%
1.1.2. Return on Assets

Shows how efficient Medisan is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Medisan to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.2% Return on Assets means that Medisan generated ¥0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Harbin Medisan Pharmaceutical Co Ltd:

  • The MRQ is 0.2%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.5%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.2%TTM0.5%-0.3%
TTM0.5%YOY-1.4%+1.9%
TTM0.5%5Y1.2%-0.7%
5Y1.2%10Y1.2%0.0%
1.1.3. Return on Equity

Shows how efficient Medisan is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Medisan to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.4% Return on Equity means Medisan generated ¥0.00 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Harbin Medisan Pharmaceutical Co Ltd:

  • The MRQ is 0.4%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.8%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.4%TTM0.8%-0.5%
TTM0.8%YOY-2.0%+2.8%
TTM0.8%5Y1.6%-0.7%
5Y1.6%10Y1.6%0.0%

1.2. Operating Efficiency of Harbin Medisan Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Medisan is operating .

  • Measures how much profit Medisan makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Medisan to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 3.6% means the company generated ¥0.04  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Harbin Medisan Pharmaceutical Co Ltd:

  • The MRQ is 3.6%. The company is operating less efficient.
  • The TTM is 0.3%. The company is operating inefficient. -1
Trends
Current periodCompared to+/- 
MRQ3.6%TTM0.3%+3.3%
TTM0.3%YOY-13.0%+13.3%
TTM0.3%5Y-0.8%+1.1%
5Y-0.8%10Y-0.8%0.0%
1.2.2. Operating Ratio

Measures how efficient Medisan is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.45 means that the operating costs are ¥1.45 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Harbin Medisan Pharmaceutical Co Ltd:

  • The MRQ is 1.450. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.366. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.450TTM1.366+0.083
TTM1.366YOY1.452-0.086
TTM1.3665Y1.331+0.035
5Y1.33110Y1.3310.000

1.3. Liquidity of Harbin Medisan Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Medisan is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.75 means the company has ¥1.75 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Harbin Medisan Pharmaceutical Co Ltd:

  • The MRQ is 1.750. The company is able to pay all its short-term debts. +1
  • The TTM is 2.364. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.750TTM2.364-0.614
TTM2.364YOY2.880-0.515
TTM2.3645Y2.621-0.256
5Y2.62110Y2.6210.000
1.3.2. Quick Ratio

Measures if Medisan is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Medisan to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.26 means the company can pay off ¥0.26 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Harbin Medisan Pharmaceutical Co Ltd:

  • The MRQ is 0.255. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.303. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.255TTM0.303-0.048
TTM0.303YOY0.670-0.366
TTM0.3035Y0.868-0.565
5Y0.86810Y0.8680.000

1.4. Solvency of Harbin Medisan Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Medisan assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Medisan to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.38 means that Medisan assets are financed with 37.9% credit (debt) and the remaining percentage (100% - 37.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Harbin Medisan Pharmaceutical Co Ltd:

  • The MRQ is 0.379. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.380. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.379TTM0.380-0.001
TTM0.380YOY0.349+0.031
TTM0.3805Y0.310+0.069
5Y0.31010Y0.3100.000
1.4.2. Debt to Equity Ratio

Measures if Medisan is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Medisan to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 61.3% means that company has ¥0.61 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Harbin Medisan Pharmaceutical Co Ltd:

  • The MRQ is 0.613. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.615. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.613TTM0.615-0.002
TTM0.615YOY0.541+0.074
TTM0.6155Y0.462+0.152
5Y0.46210Y0.4620.000

2. Market Valuation of Harbin Medisan Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Medisan generates.

  • Above 15 is considered overpriced but always compare Medisan to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 132.45 means the investor is paying ¥132.45 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Harbin Medisan Pharmaceutical Co Ltd:

  • The EOD is 99.036. Based on the earnings, the company is expensive. -2
  • The MRQ is 132.447. Based on the earnings, the company is expensive. -2
  • The TTM is 93.376. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD99.036MRQ132.447-33.411
MRQ132.447TTM93.376+39.071
TTM93.376YOY325.058-231.683
TTM93.3765Y84.676+8.700
5Y84.67610Y84.6760.000
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Harbin Medisan Pharmaceutical Co Ltd:

  • The EOD is -7.932. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -10.608. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -10.559. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.932MRQ-10.608+2.676
MRQ-10.608TTM-10.559-0.049
TTM-10.559YOY17.125-27.685
TTM-10.5595Y-4.600-5.960
5Y-4.60010Y-4.6000.000
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Medisan is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Harbin Medisan Pharmaceutical Co Ltd:

  • The EOD is 1.474. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.971. Based on the equity, the company is underpriced. +1
  • The TTM is 2.006. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.474MRQ1.971-0.497
MRQ1.971TTM2.006-0.035
TTM2.006YOY2.453-0.447
TTM2.0065Y2.270-0.264
5Y2.27010Y2.2700.000
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Harbin Medisan Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1600.077+108%-0.213+233%0.355-55%0.355-55%
Book Value Per Share--6.7386.600+2%6.557+3%6.383+6%6.383+6%
Current Ratio--1.7502.364-26%2.880-39%2.621-33%2.621-33%
Debt To Asset Ratio--0.3790.3800%0.349+9%0.310+22%0.310+22%
Debt To Equity Ratio--0.6130.6150%0.541+13%0.462+33%0.462+33%
Dividend Per Share--0.0070.082-91%0.086-91%0.091-92%0.091-92%
Eps--0.0250.037-32%-0.132+628%0.104-76%0.104-76%
Free Cash Flow Per Share---0.313-0.100-68%-0.014-96%-0.040-87%-0.040-87%
Free Cash Flow To Equity Per Share---0.334-0.243-27%-0.011-97%-0.085-75%-0.085-75%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---14.658--------
Intrinsic Value_10Y_min---12.236--------
Intrinsic Value_1Y_max---0.380--------
Intrinsic Value_1Y_min---0.373--------
Intrinsic Value_3Y_max---1.972--------
Intrinsic Value_3Y_min---1.866--------
Intrinsic Value_5Y_max---4.564--------
Intrinsic Value_5Y_min---4.165--------
Market Cap3141752858.880-34%4203917464.0004190726661.875+0%5108341806.750-18%4658541520.099-10%4658541520.099-10%
Net Profit Margin--0.0280.055-49%-0.177+735%0.120-77%0.120-77%
Operating Margin--0.0360.003+1032%-0.130+459%-0.008+122%-0.008+122%
Operating Ratio--1.4501.366+6%1.4520%1.331+9%1.331+9%
Pb Ratio1.474-34%1.9712.006-2%2.453-20%2.270-13%2.270-13%
Pe Ratio99.036-34%132.44793.376+42%325.058-59%84.676+56%84.676+56%
Price Per Share9.930-34%13.28013.238+0%16.135-18%14.716-10%14.716-10%
Price To Free Cash Flow Ratio-7.932+25%-10.608-10.5590%17.125-162%-4.600-57%-4.600-57%
Price To Total Gains Ratio59.370-34%79.39995.770-17%310.815-74%725.410-89%725.410-89%
Quick Ratio--0.2550.303-16%0.670-62%0.868-71%0.868-71%
Return On Assets--0.0020.005-55%-0.014+694%0.012-80%0.012-80%
Return On Equity--0.0040.008-55%-0.020+631%0.016-76%0.016-76%
Total Gains Per Share--0.1670.159+5%-0.127+176%0.446-63%0.446-63%
Usd Book Value--295207279.352289176098.719+2%287289784.024+3%279673303.373+6%279673303.373+6%
Usd Book Value Change Per Share--0.0220.011+108%-0.029+233%0.049-55%0.049-55%
Usd Book Value Per Share--0.9330.913+2%0.907+3%0.883+6%0.883+6%
Usd Dividend Per Share--0.0010.011-91%0.012-91%0.013-92%0.013-92%
Usd Eps--0.0030.005-32%-0.018+628%0.014-76%0.014-76%
Usd Free Cash Flow---13711441.851-4376298.806-68%-593799.169-96%-1735297.283-87%-1735297.283-87%
Usd Free Cash Flow Per Share---0.043-0.014-68%-0.002-96%-0.005-87%-0.005-87%
Usd Free Cash Flow To Equity Per Share---0.046-0.034-27%-0.002-97%-0.012-75%-0.012-75%
Usd Market Cap434818595.669-34%581822177.018579996570.004+0%706994506.054-18%644742146.382-10%644742146.382-10%
Usd Price Per Share1.374-34%1.8381.832+0%2.233-18%2.037-10%2.037-10%
Usd Profit--1098218.0192387285.657-54%-5794183.303+628%4718669.098-77%4718669.098-77%
Usd Revenue--39476309.68841138851.817-4%34600838.778+14%46164528.691-14%46164528.691-14%
Usd Total Gains Per Share--0.0230.022+5%-0.018+176%0.062-63%0.062-63%
 EOD+3 -5MRQTTM+15 -20YOY+20 -155Y+7 -2810Y+7 -28

3.2. Fundamental Score

Let's check the fundamental score of Harbin Medisan Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1599.036
Price to Book Ratio (EOD)Between0-11.474
Net Profit Margin (MRQ)Greater than00.028
Operating Margin (MRQ)Greater than00.036
Quick Ratio (MRQ)Greater than10.255
Current Ratio (MRQ)Greater than11.750
Debt to Asset Ratio (MRQ)Less than10.379
Debt to Equity Ratio (MRQ)Less than10.613
Return on Equity (MRQ)Greater than0.150.004
Return on Assets (MRQ)Greater than0.050.002
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Harbin Medisan Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.606
Ma 20Greater thanMa 509.861
Ma 50Greater thanMa 10010.244
Ma 100Greater thanMa 20012.034
OpenGreater thanClose9.800
Total0/5 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-09-302022-12-312023-03-312023-06-302023-09-30
Tax Provision  3,0142,0815,095-555,040-3,1371,903-2,719-816



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets3,434,622
Total Liabilities1,301,621
Total Stockholder Equity2,124,349
 As reported
Total Liabilities 1,301,621
Total Stockholder Equity+ 2,124,349
Total Assets = 3,434,622

Assets

Total Assets3,434,622
Total Current Assets1,534,082
Long-term Assets1,900,540
Total Current Assets
Cash And Cash Equivalents 1,047,468
Short-term Investments 83,727
Net Receivables 140,209
Inventory 186,965
Other Current Assets 75,713
Total Current Assets  (as reported)1,534,082
Total Current Assets  (calculated)1,534,082
+/- 0
Long-term Assets
Property Plant Equipment 1,015,954
Goodwill 1,340
Intangible Assets 136,575
Other Assets 74,306
Long-term Assets  (as reported)1,900,540
Long-term Assets  (calculated)1,228,175
+/- 672,365

Liabilities & Shareholders' Equity

Total Current Liabilities876,476
Long-term Liabilities425,146
Total Stockholder Equity2,124,349
Total Current Liabilities
Short Long Term Debt 275,227
Accounts payable 173,175
Other Current Liabilities 198,123
Total Current Liabilities  (as reported)876,476
Total Current Liabilities  (calculated)646,525
+/- 229,950
Long-term Liabilities
Long term Debt 210,962
Capital Lease Obligations Min Short Term Debt5,013
Other Liabilities 209,171
Deferred Long Term Liability 49,992
Long-term Liabilities  (as reported)425,146
Long-term Liabilities  (calculated)475,138
+/- 49,992
Total Stockholder Equity
Common Stock316,560
Retained Earnings 757,504
Total Stockholder Equity (as reported)2,124,349
Total Stockholder Equity (calculated)1,074,064
+/- 1,050,285
Other
Capital Stock316,560
Common Stock Shares Outstanding 316,560
Net Invested Capital 2,610,538
Net Tangible Assets 2,013,470
Net Working Capital 657,607
Property Plant and Equipment Gross 1,015,954



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
2,517,591
2,547,523
2,693,256
2,672,124
2,636,230
2,534,763
2,468,487
2,482,761
3,029,396
3,155,471
3,039,906
3,065,517
3,271,857
3,173,280
3,247,039
3,276,788
3,386,124
3,373,270
3,434,622
3,434,6223,373,2703,386,1243,276,7883,247,0393,173,2803,271,8573,065,5173,039,9063,155,4713,029,3962,482,7612,468,4872,534,7632,636,2302,672,1242,693,2562,547,5232,517,591
   > Total Current Assets 
1,656,445
1,674,158
1,743,678
1,685,592
1,652,826
1,564,705
1,454,518
1,440,160
1,390,214
1,312,456
1,199,019
1,427,194
1,563,135
1,563,135
1,600,371
1,623,659
1,700,854
1,584,291
1,534,082
1,534,0821,584,2911,700,8541,623,6591,600,3711,563,1351,563,1351,427,1941,199,0191,312,4561,390,2141,440,1601,454,5181,564,7051,652,8261,685,5921,743,6781,674,1581,656,445
       Cash And Cash Equivalents 
393,409
382,665
496,866
471,492
404,123
346,798
575,692
661,448
322,321
286,522
300,887
529,833
1,198,341
1,144,075
1,198,476
1,202,646
1,236,724
1,179,428
1,047,468
1,047,4681,179,4281,236,7241,202,6461,198,4761,144,0751,198,341529,833300,887286,522322,321661,448575,692346,798404,123471,492496,866382,665393,409
       Short-term Investments 
129,079
127,946
115,923
696,725
699,412
710,292
434,054
360,791
694,283
696,200
583,578
581,676
118,193
94,789
81,527
91,252
81,701
66,707
83,727
83,72766,70781,70191,25281,52794,789118,193581,676583,578696,200694,283360,791434,054710,292699,412696,725115,923127,946129,079
       Net Receivables 
204,793
217,891
223,963
206,988
199,977
171,342
161,574
174,570
157,767
151,750
137,202
133,622
146,674
146,674
124,864
111,948
139,361
119,345
140,209
140,209119,345139,361111,948124,864146,674146,674133,622137,202151,750157,767174,570161,574171,342199,977206,988223,963217,891204,793
       Inventory 
209,513
211,852
212,100
214,335
258,590
243,534
204,986
186,512
149,837
148,649
153,456
156,548
147,283
147,283
155,878
161,160
170,253
172,435
186,965
186,965172,435170,253161,160155,878147,283147,283156,548153,456148,649149,837186,512204,986243,534258,590214,335212,100211,852209,513
       Other Current Assets 
662,688
654,988
616,342
70,982
90,723
92,739
78,212
56,839
66,005
29,335
23,896
25,515
30,314
30,314
39,627
4,548
5,918
46,376
75,713
75,71346,3765,9184,54839,62730,31430,31425,51523,89629,33566,00556,83978,21292,73990,72370,982616,342654,988662,688
   > Long-term Assets 
861,146
873,365
949,578
986,532
983,405
970,058
1,013,969
1,042,601
1,639,182
1,843,015
1,840,887
1,638,323
1,623,585
1,610,145
1,646,667
1,653,129
1,685,269
1,788,979
1,900,540
1,900,5401,788,9791,685,2691,653,1291,646,6671,610,1451,623,5851,638,3231,840,8871,843,0151,639,1821,042,6011,013,969970,058983,405986,532949,578873,365861,146
       Property Plant Equipment 
719,818
734,983
782,858
806,691
803,192
793,104
834,041
867,290
941,377
937,942
927,033
925,345
884,206
884,206
903,814
882,449
903,616
961,729
1,015,954
1,015,954961,729903,616882,449903,814884,206884,206925,345927,033937,942941,377867,290834,041793,104803,192806,691782,858734,983719,818
       Goodwill 
9,436
9,436
9,436
9,436
9,436
9,436
9,436
9,436
9,436
9,436
9,436
9,436
9,436
9,436
9,436
500
500
500
1,340
1,3405005005009,4369,4369,4369,4369,4369,4369,4369,4369,4369,4369,4369,4369,4369,4369,436
       Intangible Assets 
72,515
23,426
70,595
70,053
69,082
68,375
67,400
66,417
65,439
64,461
63,483
62,504
61,526
60,548
61,696
71,670
75,960
113,104
136,575
136,575113,10475,96071,67061,69660,54861,52662,50463,48364,46165,43966,41767,40068,37569,08270,05370,59523,42672,515
       Other Assets 
27,524
26,608
56,568
76,949
80,007
78,128
83,014
84,544
36,762
234,624
235,395
36,536
33,731
33,731
36,697
0
0
66,924
74,306
74,30666,9240036,69733,73133,73136,536235,395234,62436,76284,54483,01478,12880,00776,94956,56826,60827,524
> Total Liabilities 
548,362
731,381
860,457
820,439
753,579
743,628
683,479
691,183
674,575
802,761
734,073
949,044
1,157,204
1,137,186
1,211,085
1,224,801
1,295,843
1,290,847
1,301,621
1,301,6211,290,8471,295,8431,224,8011,211,0851,137,1861,157,204949,044734,073802,761674,575691,183683,479743,628753,579820,439860,457731,381548,362
   > Total Current Liabilities 
449,186
633,416
765,571
723,295
650,378
644,130
587,193
588,840
556,005
501,447
417,674
536,614
509,126
509,126
588,708
597,734
662,555
653,659
876,476
876,476653,659662,555597,734588,708509,126509,126536,614417,674501,447556,005588,840587,193644,130650,378723,295765,571633,416449,186
       Short-term Debt 
102,000
202,000
202,000
180,000
189,507
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000189,507180,000202,000202,000102,000
       Short Long Term Debt 
102,000
202,000
202,000
180,000
189,507
279,507
279,507
269,782
330,000
250,000
210,000
270,280
290,000
280,287
280,191
220,223
270,264
265,192
275,227
275,227265,192270,264220,223280,191280,287290,000270,280210,000250,000330,000269,782279,507279,507189,507180,000202,000202,000102,000
       Accounts payable 
58,827
64,938
70,159
68,130
82,417
38,419
65,316
41,619
97,658
95,309
94,066
105,162
85,656
85,656
98,469
120,839
135,696
169,905
173,175
173,175169,905135,696120,83998,46985,65685,656105,16294,06695,30997,65841,61965,31638,41982,41768,13070,15964,93858,827
       Other Current Liabilities 
0
0
479,991
153,504
368,928
156,057
233,728
147,979
119,864
62,557
105,500
49,078
34,997
34,997
185,747
14,496
8,583
102,565
198,123
198,123102,5658,58314,496185,74734,99734,99749,078105,50062,557119,864147,979233,728156,057368,928153,504479,99100
   > Long-term Liabilities 
99,176
97,964
94,885
97,144
103,200
99,498
96,286
102,343
118,570
301,314
316,399
412,430
623,607
628,061
622,378
627,067
633,288
637,188
425,146
425,146637,188633,288627,067622,378628,061623,607412,430316,399301,314118,570102,34396,28699,498103,20097,14494,88597,96499,176
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
17,253
15,411
13,185
8,026
6,398
6,266
5,593
5,145
4,897
4,971
5,013
5,0134,9714,8975,1455,5936,2666,3988,02613,18515,41117,25300000000
       Other Liabilities 
99,176
97,964
94,885
97,144
103,200
99,498
96,286
102,343
101,317
105,903
101,614
199,562
200,792
200,792
202,287
0
0
207,733
209,171
209,171207,73300202,287200,792200,792199,562101,614105,903101,317102,34396,28699,498103,20097,14494,88597,96499,176
> Total Stockholder Equity
1,947,527
1,795,256
1,812,803
1,832,696
1,864,686
1,774,067
1,768,116
1,775,281
2,338,581
2,336,789
2,290,248
2,101,449
2,100,278
2,022,824
2,023,655
2,040,671
2,079,835
2,072,866
2,124,349
2,124,3492,072,8662,079,8352,040,6712,023,6552,022,8242,100,2782,101,4492,290,2482,336,7892,338,5811,775,2811,768,1161,774,0671,864,6861,832,6961,812,8031,795,2561,947,527
   Common Stock
316,600
316,600
316,600
316,600
316,600
316,600
316,600
316,600
316,600
316,600
316,600
316,600
316,600
316,600
316,600
0
0
316,560
316,560
316,560316,56000316,600316,600316,600316,600316,600316,600316,600316,600316,600316,600316,600316,600316,600316,600316,600
   Retained Earnings 
511,534
360,112
390,291
529,187
561,176
470,558
464,607
471,772
1,035,072
1,033,280
986,739
797,940
719,315
719,315
720,146
570,719
609,883
749,552
757,504
757,504749,552609,883570,719720,146719,315719,315797,940986,7391,033,2801,035,072471,772464,607470,558561,176529,187390,291360,112511,534
   Capital Surplus 0000000000000000000
   Treasury Stock0000000000000000000
   Other Stockholders Equity 0000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,188,984
Cost of Revenue-445,220
Gross Profit743,765743,765
 
Operating Income (+$)
Gross Profit743,765
Operating Expense-1,175,329
Operating Income13,655-431,564
 
Operating Expense (+$)
Research Development103,521
Selling General Administrative519,494
Selling And Marketing Expenses-
Operating Expense1,175,329623,016
 
Net Interest Income (+$)
Interest Income28,103
Interest Expense-22,922
Other Finance Cost-1,148
Net Interest Income4,033
 
Pretax Income (+$)
Operating Income13,655
Net Interest Income4,033
Other Non-Operating Income Expenses-
Income Before Tax (EBT)76,57213,655
EBIT - interestExpense = -22,922
68,997
91,919
Interest Expense22,922
Earnings Before Interest and Taxes (EBIT)-99,494
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax76,572
Tax Provision-11,221
Net Income From Continuing Ops65,35065,350
Net Income68,997
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--4,033
 

Technical Analysis of Medisan
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Medisan. The general trend of Medisan is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Medisan's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Harbin Medisan Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 10.46 < 10.60 < 10.79.

The bearish price targets are: 9.2 > 6.74.

Tweet this
Harbin Medisan Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Harbin Medisan Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Harbin Medisan Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Harbin Medisan Pharmaceutical Co Ltd. The current macd is -0.00450028.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Medisan price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Medisan. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Medisan price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Harbin Medisan Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartHarbin Medisan Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Harbin Medisan Pharmaceutical Co Ltd. The current adx is 21.45.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Medisan shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Harbin Medisan Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Harbin Medisan Pharmaceutical Co Ltd. The current sar is 10.52.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Harbin Medisan Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Harbin Medisan Pharmaceutical Co Ltd. The current rsi is 48.61. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Harbin Medisan Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartHarbin Medisan Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Harbin Medisan Pharmaceutical Co Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Medisan price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
Harbin Medisan Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartHarbin Medisan Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Harbin Medisan Pharmaceutical Co Ltd. The current cci is 13.74.

Harbin Medisan Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartHarbin Medisan Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Harbin Medisan Pharmaceutical Co Ltd. The current cmo is -1.442923.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Harbin Medisan Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartHarbin Medisan Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Harbin Medisan Pharmaceutical Co Ltd. The current willr is -50.75757576.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Medisan is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Harbin Medisan Pharmaceutical Co Ltd Daily Williams %R ChartHarbin Medisan Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Harbin Medisan Pharmaceutical Co Ltd.

Harbin Medisan Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Harbin Medisan Pharmaceutical Co Ltd. The current atr is 0.39395247.

Harbin Medisan Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartHarbin Medisan Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Harbin Medisan Pharmaceutical Co Ltd. The current obv is 197,146,649.

Harbin Medisan Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartHarbin Medisan Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Harbin Medisan Pharmaceutical Co Ltd. The current mfi is 63.03.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Harbin Medisan Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartHarbin Medisan Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Harbin Medisan Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-23BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-26BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Harbin Medisan Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Harbin Medisan Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.606
Ma 20Greater thanMa 509.861
Ma 50Greater thanMa 10010.244
Ma 100Greater thanMa 20012.034
OpenGreater thanClose9.800
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Medisan with someone you think should read this too:
  • Are you bullish or bearish on Medisan? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Medisan? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Harbin Medisan Pharmaceutical Co Ltd

I send you an email if I find something interesting about Harbin Medisan Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Harbin Medisan Pharmaceutical Co Ltd.

Receive notifications about Harbin Medisan Pharmaceutical Co Ltd in your mailbox!